Title: Tumor Targeting with an AB.Fab
Dr. Mark S. Dennis, Senior Scientist, Department of Antibody Engineering, Genentech, Inc., South San Francisco, USA

Title: Chelating Agents as Treatments for Colon Cancer? The Gastrin-Iron Story
Dr. Graham Baldwin, University of Melbourne Department of Surgery, Australia

Title: Immunotherapy for Gastrointestinal Malignancy: Current Experience and Future Challenges
Dr. M Asif Chaudry, University College London, UK

Title: A Novel Tumor Suppressor that Inhibits EGFR Signaling
Dr. Noriko Gotoh, Associate Professor, Division of Systems Biomedical Technology, Institute of Medical Science, University of Tokyo, Japan

Title: Thymosin β4: A Novel Therapeutic Target for Colorectal Cancer
Dr. Yeu Su, Institute of Biopharmaceutical Science, National Yang-Ming University, Taiwan, China

Title: Cancer Chemoprevention and Biomarkers
Dr. Jianyu Rao, Department of Pathology and Laboratory Medicine, UCLA, USA

Title: Sensitizing cells to Radiation and Chemotherapy using Sphingolipid Modifiers
Dr. James S. Norris, Professor and Chairman Department of Microbiology and Immunology, Medical University of South Carolina Charleston, USA

Title: N-hydroxy-N-(4-butyl-2-methylphenol) Formamidine (HET0016), a Novel Anti-angiogenic and Anti-tumoral Drug
Dr. Austin Meng Guo, Senior Bioscientific Staff/Assistant Scientist, Henry Ford Health System, Eye Care Services Research, USA

Title: Antihypertensives as Novel Antineoplastics: The Use of Angiotensin Blockade Therapies in Pancreatic Ductal Adenocarcinoma
Dr. Hwyda Arafat, Assistant Professor, Departments of Surgery Pathology, Anatomy, and Cell Biology, Thomas Jefferson University, USA